98%
921
2 minutes
20
Objective: To evaluate the clinical efficacy of nasal high-flow oxygen therapy in patients with acute left heart failure and hypoxemia.
Methods: From July 2016 to November 2018, patients with acute left heart failure complicated with hypoxemia treated in the Department of Critical Medicine of Yantai Affiliated Hospital of Binzhou Medical University were retrospectively observed (a total of 140 cases met the inclusion criteria). They were randomly divided into two groups, with 70 cases in each group. Patients were given continuous ECG monitoring, improved blood gas analysis test, and recorded HR, RR, map, SaO, pH, PaO, PaCO, and Lac, perfect examination and color Doppler echocardiography, and record NT-proBNP and EF before and 24 hours after treatment. The effective rates of the two groups before and after oxygen therapy were detected.
Results: There were 67 patients with high-flow oxygen therapy group improvement, 95.7% improvement rate, and 55 patients with general oxygen therapy group improvement rate. The treatment improvement rate was 78.6%. A total of 67 patients were treated with high-flow oxygen therapy. After high-flow oxygen therapy, HR ( = 18.8, ≤ 0.05), RR ( = 19.7, ≤ 0.05), MAP ( = 12.1, ≤ 0.05), PaCO ( = 9.53, ≤ 0.05), Lac ( = 8.69, ≤ 0.05), and NT-proBNP ( = 7.03, ≤ 0.05) were significantly lower than before. SaO ( = -12.4, ≤ 0.05), pH ( = -12.2, ≤ 0.05), PaO ( = -17.7, ≤ 0.05), and EF ( = -13.4, ≤ 0.05) were significantly higher than before. A total of 55 patients were in the general oxygen therapy group. After administration of ordinary oxygen therapy, HR ( = 18.2, ≤ 0.05), RR ( = 10.8, ≤ 0.05), MAP ( = 13.1, ≤ 0.05), PaCO ( = 15.8, ≤ 0.05), Lac ( = 7.1, ≤ 0.05), and NT-proBNP ( = 10, ≤ 0.05) were significantly lower than before. SaO ( = -15.5, ≤ 0.05), pH ( = -4.5, ≤ 0.05), PaO ( = -20, ≤ 0.05), and EF value ( = -7.7, ≤ 0.05) were significantly higher than before.
Conclusion: High-flow oxygen therapy and general oxygen therapy have an obvious curative effect on patients with acute left heart failure and hypoxemia. Compared with the two, high-flow oxygen therapy is more effective. After high-flow oxygen therapy and general oxygen therapy in patients with acute left heart failure and hypoxia, HR, RR, MAP, SaO, pH, PaO, PaCO, Lac, EF, and NT-proBNP value all improved, and the improvement of high-flow oxygen therapy was greater.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8938071 | PMC |
http://dx.doi.org/10.1155/2022/7117508 | DOI Listing |
BMC Med Imaging
August 2025
Department of Radiology, Shandong Provincial Hospital, Affiliated to Shandong First Medical University, No.324 Jingwu Road, Jinan, Shandong, China.
Background: Perivascular adipose tissue has been shown to play a role in cardiovascular disease. This provides evidences that perivascular fat density (PFD) may have a correlation with abdominal aortic aneurysm (AAA). The aim of study was to investigate the association between PFD on computed tomography angiography (CTA) and AAA expanding rate.
View Article and Find Full Text PDFJ Transl Med
August 2025
Guizhou University Medical College, Guiyang, Guizhou, China.
Background: Clear cell renal cell carcinoma (ccRCC) is the most common subtype of renal cell carcinoma, presenting significant challenges in diagnosis and treatment. Despite recent advancements in targeted therapies and immune checkpoint inhibitors, drug resistance remains a major obstacle in metastatic ccRCC. As a member of the AAA + ATPase superfamily, TRIP13 has been implicated in tumorigenesis across various cancers.
View Article and Find Full Text PDFRev Cardiovasc Med
July 2025
Department of Cardiovascular Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Ruijin Er Road, 200025 Shanghai, China.
Background: Abdominal aortic aneurysm (AAA) is a major public health challenge and presents high mortality due to diagnostic and therapeutic difficulties. This study investigated the role of high-mobility group box2 (HMGB2) and the HMGB2-triggering receptor expressed on the myeloid cell (TREM) pathway in male AAA patients. The goal was to evaluate HMGB2 as a novel biomarker and to elucidate its contribution to the pathogenesis of AAA.
View Article and Find Full Text PDFJ Vasc Surg
August 2025
Department of Applied Mathematics, Technical Medical Centre, University of Twente, Enschede, the Netherlands.
Objective: Recent findings show that patients with abdominal aortic aneurysm (AAA) sac regression after endovascular repair (EVAR) have significantly better long-term outcomes than patients with a stable or expanding sac. Previous studies have not yet identified strong predictors of sac regression, but suggest that anatomical AAA parameters might play a role in the remodeling. This study aimed to conduct a comprehensive analysis of preoperative AAA anatomy to identify predictors of sac regression 1 year after EVAR.
View Article and Find Full Text PDFGlob Heart
June 2025
Department of Heart Disease, Haukeland University Hospital, Bergen, Norway.
Background And Objectives: Abdominal aortic (AA) aneurysms (AAA) are often incidental findings and preceded by a long period of subclinical growth in diameter. Patients may present with life-threatening complications. Therefore, screening programmes for AAA in primary care are proposed in several European countries, and opportunistic AAA screening during echocardiography is also advocated.
View Article and Find Full Text PDF